Bacteroides fragilis
Bacteroides fragilis is an
Bacteroides fragilis | |
---|---|
Scientific classification | |
Domain: | Bacteria |
Phylum: | Bacteroidota |
Class: | Bacteroidia |
Order: | Bacteroidales |
Family: | Bacteroidaceae |
Genus: | Bacteroides |
Species: | B. fragilis
|
Binomial name | |
Bacteroides fragilis (Veillon and Zuber 1898) Castellani and Chalmers 1919 (Approved Lists 1980)
|
Habitat
Bacteroides fragilis resides in the human gastrointestinal tract and is essential to healthy gastrointestinal function such as
Morphology
Cells of B. fragilis are rod-shaped to pleomorphic with a cell size range of 0.5-1.5 x 1.0-6.0 μm.
Metabolism & mutualism in the gut microbiome
B. fragilis is an aerotolerant, anaerobic chemoorganotroph capable of fermenting a wide variety of glycans available in the human gut microenvironment including glucose, sucrose, & fructose. B. fragilis can also catabolize a variety of biopolymers, polysaccharides, and glycoproteins into smaller molecules which can then be used and further broken down by other microbes. Fatty acids produced by the fermentation of carbohydrates can serve as a source of energy for the host.[6][4] Cytochrome bd oxidase is essential for oxygen consumption in B. fragilis and can allow other obligate anaerobes to survive in the now oxygen-reduced microenvironment.[7][6] Animals lacking gut bacteria require 30% more caloric intake to maintain body mass.[6]
Environment-sensing systems
The complex environmental-sensory system allows B. fragilis to survive/adapt in the ever-changing human gut microbiome. This system is composed of/designed to effectively handle:
Bacteriocins: B. fragilis intestinal isolates secrete high levels of bacteriocin proteins and are resistant to other bacteriocins secreted by other closely related isolates. This mechanism is believed to reduce the level of intra-specific competition.[4]
Bile salt resistance: Utilizes enzymes such as bile salt hydrolase to resist the degrading effects of bile salts. Detergent activity of bile salts can permeabilize bacterial membranes which can eventually lead to membrane collapse and/or cell damage.[4]
Oxidative Stress Response: Proteins such as catalase, superoxide dismutase, & alkyl hydroperoxide reductase protect the organism from harmful oxygen radicals. This permits growth in the presence of nanomolar concentrations of O2.[4]
Antibiotic resistance
Member of the genus Bacteroides are characterized with having the highest numbers of antibiotic resistance mechanisms accompanied by the highest resistance rates amongst anaerobic bacteria. The high resistance to antibiotics of B.fragilis is mainly attributed to genetic plasticity.[8] Species of the Bacteroidaceae have displayed increasing resistance to antimicrobial agents such as cefoxitin, clindamycin, metronidazole, carbapenems, & fluoroquinolones.[6][4]
Resistance Reservoirs: Bacteroides species accumulate a variety of antibiotic/antimicrobial resistance genes as they reside in the gastrointestinal tract. This allows the genetic transfer of these genes to other Bacteroides species and possibly other more virulent bacteria leading to an overall increase in multi-drug resistance. This is exacerbated by the tendency of resistance genes to be relatively stable even without the presence of the antibiotic.[6]
Epidemiology and pathogenesis
The B. fragilis group is the most commonly isolated
This group was formerly classified as subspecies of B. fragilis (i.e. B. f. ssp. fragilis, B. f. ssp. distasonis, B. f. ssp. ovatus, B. f. ssp. thetaiotaomicron, and B. f. ssp. vulgatus). They have been reclassified into distinct species on the basis of DNA homology studies.]
Although the B. fragilis group is the most common species found in clinical specimens, it is the least common Bacteroides present in fecal microbiota, comprising only 0.5% of the bacteria present in stool. Their pathogenicity partly results from their ability to produce capsular polysaccharide, which is protective against phagocytosis[6] and stimulates abscess formation.[3]
Bacteroides fragilis is involved in 90% of anaerobic
Anti-inflammatory effects
B. fragilis
See also
References
- PMID 15466707.
- ^ "Bacteroides fragilis". Johns Hopkins ABX Guide.
- ^ a b Levinson W (2010). Review of Medical Microbiology and Immunology (11th ed.).
- ^ )
- ^ "BacMap". bacmap.wishartlab.com. Retrieved 2021-11-13.
- ^ PMID 17934076.
- S2CID 4420207.
- ^ S2CID 201203450.
- PMID 20067390.
- PMID 8324167.
- ^ Bacteroides infections at eMedicine
- PMID 20025984.
- S2CID 35945399.
- ^ PMID 34025663.
External links
- Bacteroides references in Baron's Medical Microbiology (online at the NCBI bookshelf).
- Type strain of Bacteroides fragilis at BacDive - the Bacterial Diversity Metadatabase